12.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AUPH Giù?
Forum
Previsione
Frazionamento azionario
Aurinia Pharmaceuticals Inc Azioni (AUPH) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
12.08%
70.01
|
62.47 | 67.77 | 57.19 | 50.30 |
Cost Of Revenue |
17.02%
7.115
|
8.574 | 6.035 | 8.909 | 7.752 |
Gross Profit |
16.70%
62.89
|
53.89 | 61.74 | 48.28 | 42.55 |
|
33.60%
42.81
|
32.04 | 49.99 | 49.80 | 55.80 |
Benefits Costs and Expenses |
25.54%
47.85
|
38.12 | 52.96 | 55.71 | 60.31 |
Costs And Expenses |
22.91%
49.92
|
40.62 | 56.02 | 58.70 | 63.56 |
Operating Income/Loss |
8.07%
20.08
|
21.85 | 11.75 | -1.513 | -13.25 |
Income/Loss From Continuing Operations Before Tax |
9.01%
22.16
|
24.35 | 14.81 | 1.478 | -10.01 |
Income Tax Expense/Benefit |
36.02%
0.643
|
1.005 | 0.457 | 0.756 | 0.739 |
Income/Loss From Continuing Operations After Tax |
7.84%
21.51
|
23.34 | 14.35 | 0.722 | -10.75 |
|
7.84%
21.51
|
23.34 | 14.35 | 0.722 | -10.75 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
2.91%
134.87
|
138.92 | 143.05 | 143.33 | 144.01 |
Diluted Average Shares |
3.96%
137.53
|
143.20 | 145.65 | 144.11 | 144.01 |
Basic Earnings Per Share |
5.88%
0.16
|
0.17 | 0.10 | 0.01 | -0.07 |
Diluted Earnings Per Share |
0.00%
0.16
|
0.16 | 0.10 | 0.01 | -0.07 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):